CClinicalTrials.gg
Status unknownNCT03459989STTUpdated Aug 28, 2018

Comparison Between Fetal Thigh Soft Tissue Versus Hadlock's Formula in Estimation of Fetal Weight by Ultrasound

An observational study in Estimation of Fetal Weight, sponsored by Ain Shams University. Status unknown at 1 site in Egypt. Open to female participants aged 19 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-08-28.

Sponsored by Ain Shams University · Observational

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
19 Years to 40 Years
Sex
Female
01

Study summary

We are going to do 2d ultrasound to compare between hadlock's formula and thigh soft tissue formula in expecting the after birth fetal weight and to find which of these formulas to be more accurate

Read the detailed description

We are going to do 2d ultrasound to 200 pregnant women between 38 weeks to 40 weeks singleton pregnancy in Ain Shams University Maternity Hospital to measure the expected fetal weight by hadlock's formula and thigh soft tissue formula and then we are going to measure the actual fetal weight after birth of these 200 fetuses and to find out which formula to be more accurate in estimation of fetal weight

02

Conditions studied

  • Estimation of Fetal Weight

Keywords

  • hadlock
  • thigh soft tissue
03

Who can participate

Ages eligible
19 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study population comprises 200 pregnant women at 38 to 40 week of gestation attending outpatient clinic and emergency Ain Shams University Maternity Hospital, Obstetrics and Gynaecology Department, Faculty of medicine.

Inclusion criteria

  1. Gestational age 38 - 40 wks
  2. Singleton uncomplicated pregnancies
  3. Normal amniotic fluid volume

Exclusion criteria

Exclusion Criteria:

Women with one of the following conditions:

  1. Fetuses with congenital anomalies,
  2. The biometric measurements of those, which were unable to ascertain due to reasons like deeply engaged head, very thick abdominal wall etc.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • pregnant women

    we will measure expected fetal weight by ultrasound by hadlock's formula and thigh soft tissue for each pregnant woman

    Diagnostic Test: Ultrasound

Interventions

  • Diagnostic testUltrasound

    Samsung H60 Ultrasound

05

What researchers measure

Primary outcomes

  1. Fetal weight

    hadlock's 4th formula and thigh soft tissue formula

    Time frame: 38 weeks to 40 weeks of gestation

06

Study locations

1 of 1 sites recruiting
  • Ain Shams Universitiy
    Cairo, Egypt
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03459989
Lead sponsor
Ain Shams University
Responsible party
Mohamed abd elfatah elsenity (Lecturer, Ain Shams University) — Principal investigator
First posted
Mar 9, 2018
Start date
May 15, 2017
Primary completion
Sep 1, 2018 (estimated)
Completion
Oct 30, 2018 (estimated)
Last update
Aug 28, 2018

Study contacts

Mohamed Elsenity, Lecturer
Contact
m.elsenity@yahoo.com
+201226573332
Adel SH Salah El-Din, Professor
study chair · Ain Shams University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion